The APhA Annual Meeting & Exposition is a comprehensive meeting for pharmacy professionals and future leaders in pharmacy where you can learn about leadership, career opportunities, and patient safety from nationally recognized experts. The 2023 Annual Meeting is held March 24–27 in Phoenix, AZ.

What you can expect at this year’s conference

APhA2023 Schedule at a Glance

Thursday, March 23
8:30 am–5:30 pm: APhA 2023 Pain Institute: Advocate and Communicate: Pain Management, OUD and SUD (pre-registration required)
8:00 am–6:15 pm: DigitalHealth.Rx 2023 (pre-registration required)

Friday, March 24
7:00 am–6:00 pm: Certificate Training Programs (pre-registration required)
7:00 am–1:00 pm: Federal Pharmacy Forum
8:00 am–4:30 pm: Education Sessions
8:00 am–4:30 pm: Day of Science
2:45 pm–5:15 pm: APhA House of Delegates–First Session
5:00 pm–6:30 pm: Women in Pharmacy Leadership Development Forum (ticket required)
5:30 pm–7:00 pm: APhA-PAC Reception (ticket required)
6:00 pm–8:00 pm: APhA-ASP Opening General Session
7:00 pm–9:00 pm: APhA Opening Reception in the Exposition

Saturday, March 25
6:00 am–8:00 am: Education Satellite Symposia
7:45 am–8:45 am: Education Sessions
9:00 am–11:00 am: APhA Opening General Session
9:00 am–6:00 pm: Contributed Papers Poster Presentations
11:00 am–3:00 pm: Exposition and Presentation Theaters
12:30 pm–2:30 pm: Meet the Researchers: Contributed Papers Poster Presentations
2:30 pm–4:45 pm: Day of Science
2:30 pm–5:45 pm: Education Sessions
7:00 pm–8:00 pm: APhA-ASP Awards Reception
8:00 pm–9:30 pm: APhA-ASP Awards Celebration

Sunday, March 26
6:00 am–8:00 am: Education Satellite Symposia
7:15 am–8:45 am: Education Sessions
9:00 am–11:00 am: APhA Second General Session
9:00 am–3:00 pm: APhA Contributed Papers Poster Presentations
11:00 am–3:00 pm: Exposition and Presentation Theaters
1:00 pm–4:30 pm: Education Sessions
4:30 pm–5:30 pm: APhA Awards Program
5:00 pm–11:00 pm: Networking Events
5:30 pm–7:00 pm: 2023 APhA Immunization Champion Awards
7:00 pm–7:45 pm: Remington Honor Medal Lecture
8:15 pm–9:30 pm: Remington Dinner (ticket required)

Monday, March 27
8:00 am–9:00 am: APhA Foundation Annual Contributors’ Breakfast (by invitation only)
8:30 am–12:00 pm: Education Sessions
1:30 pm–4:30 pm: APhA House of Delegates–Final Session
5:30 pm–7:30 pm: APhA Closing Reception at Palma

Schedule is subject to change; all times listed are local Phoenix time.

Read More On: APHA

Post Conference Wrap Up

Ilisa Bernstein, APhA Interim CEO, Kicks Off Yearly Gathering

Ilisa Bernstein The American Pharmacists Association (APhA) 2023 Annual Meeting & Exposition convened on Thursday, March 23, 2023, in Phoenix, Arizona. Ilsa Bernstein (right), interim CEO, got things rolling during the Opening Session on Saturday, March 25, and APhA President Theresa Tolle commended pharmacists on their achievements during the COVID-19 pandemic. Read more.

Detailing RAAS Therapy in Heart, Kidney Disease Patients

Joe Saseen In an APhA2023 education session presented titled “Back to Basics: Not Talkin’ tRAASh,” Joe Saseen (right), PharmD, BCSP, BCACP, FAPhA, focused on the renin-angiotensin-aldosterone system (RAAS) system, its effect on blood pressure regulation, and the benefits and risk of the drugs that block this system. He emphasized how RAAS therapy is beneficial in patients with kidney and heart disease. Read more.

COVID-19''s Impact on Antimicrobial Stewardship

Joe Saseen In an APhA2023 education session titled “The New Big Superbug: Impact on Antimicrobial Stewardship and Pharmacy Practice,” Timothy Gauthier, PharmD, BCSP, BCIDP (above), focused on the consequences that COVID-19 had on antimicrobial stewardship due to increased antibiotic use. Read more.

Latest FDA News and Updates Affecting Pharmacy Practice

This session packed in the latest updates from the FDA—from important regulatory updates to the latest enforcement updates and concerns—while providing insight into the FDA’s future priorities. In addition, Drs. Lindsay Wagner and Connie Jung updated activities that affected pharmacy practice during the past year. Learn more about the FDA’s available resources for pharmacists.

New Pharmacist Recommendation Series Video

In the latest Pharmacist Recommendation Series video, U.S. Pharmacist Editor-in-Chief Robert Davidson discusses Konvomep with Clinical Pharmacist Tammie Lee Demler. In this installment, Dr. Demler explains how Konvomep may give patients, particularly people with difficulty swallowing pills or capsules, an option for treatment tailored to their needs. Click here to view video.

Delineating Nonsterile Compounding and Beyond-Use Dates

Joe Saseen In an APhA2023 education session titled “Back to the Basics: Nonsterile Compounding 101,” Matt Martin, PharmD, BCSCP (above), explained the FDA’s role in 503 compounding, when to utilize certificate of analysis for active ingredients in compounds, how to assign beyond-use dates to nonsterile preparations, and how to calculate the Minimum Accurately Weighable Quantity for balances as defined by the FDA. Read more.